Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Chien

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Addictive Diseases|January 1, 1978
Substance use and abuse among the community elderly: the medical aspectC P Chien, E J Townsend, A Ross-Townsend
International Journal of Law and Psychiatry|January 1, 1987
Forensic psychiatry in Taiwan: civil litigationS H Kuo, C P Chien, M J Mills
Current Therapeutic Research, Clinical and Experimental|January 1, 1970
Double-blind study comparing the intramuscular usage of an acridan derivative, SK&F 14336, to chlorpromazineC P Chien, M Sah, G C Dubiel, et al.
Psychopharmacology Bulletin|July 1, 1977
The measurement of persistent dyskinesia by piezoelectric recording and clinical rating scalesC P Chien, K Jung, A Ross-Townsend, et al.
The American Journal of Psychiatry|December 1, 1976
Generic and trade-name antipsychotic drugs: clinical equivalenceC P Chien, R Labrie, C G Park, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 1, 1994
Plasma reduced haloperidol/haloperidol ratios in schizophrenic patients treated with high dosages of haloperidolW H Chang, Y S Shieh, H C Liu, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1996
Disposition of remoxipride in Chinese schizophrenic patientsS K Lin, W H Chang, C P Chien, et al.
The American Journal of Psychiatry|April 1, 1983
A comparison of patients who refuse and consent to neuroleptic treatmentS R Marder, A Mebane, C P Chien, et al.
Hospital & Community Psychiatry|July 1, 1984
A study of medication refusal by involuntary psychiatric patientsS R Marder, E Swann, W J Winslade, et al.
Psychiatry Research|July 28, 1995
Ketone reductase activity and reduced haloperidol/haloperidol ratios in haloperidol-treated schizophrenic patientsH F Huang, M W Jann, Y T Tseng, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Addictive Diseases|January 1, 1978
Substance use and abuse among the community elderly: the medical aspectC P Chien, E J Townsend, A Ross-Townsend
International Journal of Law and Psychiatry|January 1, 1987
Forensic psychiatry in Taiwan: civil litigationS H Kuo, C P Chien, M J Mills
Current Therapeutic Research, Clinical and Experimental|January 1, 1970
Double-blind study comparing the intramuscular usage of an acridan derivative, SK&F 14336, to chlorpromazineC P Chien, M Sah, G C Dubiel, et al.
Psychopharmacology Bulletin|July 1, 1977
The measurement of persistent dyskinesia by piezoelectric recording and clinical rating scalesC P Chien, K Jung, A Ross-Townsend, et al.
The American Journal of Psychiatry|December 1, 1976
Generic and trade-name antipsychotic drugs: clinical equivalenceC P Chien, R Labrie, C G Park, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 1, 1994
Plasma reduced haloperidol/haloperidol ratios in schizophrenic patients treated with high dosages of haloperidolW H Chang, Y S Shieh, H C Liu, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1996
Disposition of remoxipride in Chinese schizophrenic patientsS K Lin, W H Chang, C P Chien, et al.
The American Journal of Psychiatry|April 1, 1983
A comparison of patients who refuse and consent to neuroleptic treatmentS R Marder, A Mebane, C P Chien, et al.
Hospital & Community Psychiatry|July 1, 1984
A study of medication refusal by involuntary psychiatric patientsS R Marder, E Swann, W J Winslade, et al.
Psychiatry Research|July 28, 1995
Ketone reductase activity and reduced haloperidol/haloperidol ratios in haloperidol-treated schizophrenic patientsH F Huang, M W Jann, Y T Tseng, et al.
Pageof 4